Dividend Stock Analysis

Johnson and Johnson: This Healthcare Giant is Still a Buy

Google+ Pinterest LinkedIn Tumblr

Johnson and Johnson (NYSE: JNJ) and its subsidiaries are engaged in the research and development, manufacture and sale of a range of products in the health care field. It has more than 250 operating companies conducting business in 60 countries worldwide. The company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics.

See Full Analysis

Comments are closed.

Tweet
Share
Pin
Share